Resonance Health (ASX:RHT) PE Ratio without NRI: 46.00 (As of Jun. 24, 2026) — 37% Below Median


What is Resonance Health PE Ratio without NRI?

Resonance Health ASX:RHT +4.55% PE Ratio without NRI is 46.00 as of Jun. 24, 2026, which is 37% below its 10-year median of 73.33. The stock has 6 warning signs investors should review. Among 439 Healthcare Providers & Services companies, Resonance Health ranks worse than 79.04% on this metric.

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. As of today (2026-06-24), Resonance Health's share price is A$0.046. Resonance Health's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.00. Therefore, Resonance Health's PE Ratio without NRI for today is 46.00.

During the past 13 years, Resonance Health's highest PE Ratio without NRI was 185.00. The lowest was 17.00. And the median was 73.33.

Resonance Health's EPS without NRI for the six months ended in Dec. 2025 was A$0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.00.

As of today (2026-06-24), Resonance Health's share price is A$0.046. Resonance Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.00. Therefore, Resonance Health's PE Ratio (TTM) for today is 46.00.

During the past years, Resonance Health's highest PE Ratio (TTM) was 185.00. The lowest was 17.00. And the median was 73.33.

Resonance Health's EPS (Diluted) for the six months ended in Dec. 2025 was A$0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.00.

Resonance Health's EPS (Basic) for the six months ended in Dec. 2025 was A$0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.00.


Resonance Health  (ASX:RHT) PE Ratio without NRI Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio without NRI measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.


Resonance Health PE Ratio without NRI Related Terms


Resonance Health PE Ratio without NRI Historical Data

* Premium members only.

The historical data trend for Resonance Health's PE Ratio without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Resonance Health PE Ratio without NRI Chart

Resonance Health Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
PE Ratio without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 155.00 At Loss At Loss N/A At Loss

Resonance Health Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
PE Ratio without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only At Loss N/A At Loss At Loss At Loss

ASX:RHT vs VEEV, BTSG, TEM: PE Ratio without NRI Comparison

For the Health Information Services subindustry, Resonance Health's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Resonance Health PE Ratio without NRI vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Resonance Health's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Resonance Health's PE Ratio without NRI falls into.



Resonance Health PE Ratio without NRI Calculation

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. Regular PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than regular PE Ratio.

Resonance Health's PE Ratio without NRI for today is calculated as

PE Ratio without NRI=Share Price/ EPS without NRI
=0.046/0.001
=46

Resonance Health's Share Price of today is A$0.046.
For company reported semi-annually, Resonance Health's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months.

For Forward PE Ratio, the earnings are the expected earnings for the next twelve months.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio without NRI →
What does a PE Ratio without NRI of 46.00 mean?
Resonance Health (ASX:RHT) has a PE Ratio without NRI of 46.00 as of Jun. 24, 2026. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Resonance Health and its competitors. This is 37% below median its historical median of 73.33. Over the past decade, Resonance Health's PE Ratio without NRI has ranged from 17.00 to 185.00. According to the industry distribution chart, Resonance Health ranks #347 out of 439 companies in the Healthcare Providers & Services industry, placing it in the top 79%.
Is Resonance Health's PE Ratio without NRI too high?
Resonance Health's current PE Ratio without NRI of 46.00 is 37% below median its 10-year median of 73.33. Over the past 10 years, this metric has ranged from a low of 17.00 to a high of 185.00. The Healthcare Providers & Services industry median PE Ratio without NRI is 19.42. Resonance Health's value of 46.00 is 136.9% above this industry median. Based on the distribution chart, Resonance Health ranks #347 out of 439 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Resonance Health's PE Ratio without NRI compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Resonance Health ranks #347 out of 439 companies for PE Ratio without NRI. This places Resonance Health in the lower half of its industry. The industry median PE Ratio without NRI is 19.42. Resonance Health's value of 46.00 is 136.9% above this benchmark. Historically, Resonance Health's own PE Ratio without NRI has ranged from 17.00 to 185.00 over the past decade. While the company's 10-year median is 73.33 vs. the industry median of 19.42, Resonance Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio without NRI for a Healthcare Providers & Services company?
The median PE Ratio without NRI among Healthcare Providers & Services companies is 19.42, based on 439 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio without NRI significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Resonance Health's current PE Ratio without NRI of 46.00 is 136.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio without NRI mean?
A high PE Ratio without NRI can signal that a stock is expensive relative to its fundamentals. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Resonance Health and its competitors. For the Healthcare Providers & Services industry, the median PE Ratio without NRI is 19.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Resonance Health's current PE Ratio without NRI is 46.00, which is 37% below median its own 10-year median of 73.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Resonance Health stock overvalued right now?
Based on GuruFocus' analysis, Resonance Health (ASX:RHT) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.12, compared to a current price of A$0.05 — trading 61.7% below its estimated fair value. The current PE Ratio without NRI is 46.00, which is 37% below median its 10-year median of 73.33 and 136.9% above the Healthcare Providers & Services industry median of 19.42. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio without NRI calculated?
PE Ratio without NRI is calculated from a company's financial statements. For Resonance Health (ASX:RHT), the current PE Ratio without NRI is 46.00 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Resonance Health Business Description

Address 141 Burswood Road, Level 1, Burswood, Perth, WA, AUS, 6100
Resonance Health Ltd is engaged in the development and commercialisation of software-as-medical-device (SaMD) technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. The Group's core SaMD product is FerriScan, a non-invasive liver analysis technology used for the assessment of iron in the liver. The Company also has several AI-assisted SaMDs including FerriSmart, HepaFatSmart, and LiverSmart. Its business segments are; SaMD1 which derives key revenue, Corporate, TrialsWest, and Resonance Clinica. Geographically, it generates maximum revenue from the Asia Pacific region and the rest from North America, and Europe, Middle East and Africa (EMEA) regions.